BCL6 and diffuse large B-cell lymphoma: However, in FL and DLBCL, CBP mutations lead to a deficient CBP, which is unable to acetylate these substrates and the BCL6-nuclear receptor corepressor 2 (SMRT)-HDAC3 causes unopposed deacetylation.